Evidence supporting the use of: Maitake mushroom
For the health condition: Acquired Immune Deficiency Syndrome

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Maitake mushroom (Grifola frondosa) has been investigated for its potential immunomodulatory effects, particularly in the context of supporting individuals with Acquired Immune Deficiency Syndrome (AIDS). The interest in maitake arises from its rich content of beta-glucans, complex polysaccharides known to stimulate the immune system. Several in vitro and animal studies have demonstrated that maitake extracts can enhance macrophage activity, increase natural killer (NK) cell function, and promote cytokine production. Small-scale human studies and preliminary clinical trials have also explored maitake supplementation in people living with HIV/AIDS. For example, a pilot study published in the Journal of Alternative and Complementary Medicine (2002) reported modest improvements in immune parameters and quality of life among HIV-positive subjects taking maitake extract. However, these studies are limited by small sample sizes, lack of rigorous controls, and short durations. There is insufficient high-quality clinical evidence to conclude that maitake mushroom has a significant therapeutic effect on HIV/AIDS progression or outcomes. While it has a history of use in traditional medicine for general immune support, its application specifically for AIDS is driven primarily by early scientific investigation rather than longstanding traditional use. Therefore, while there is some scientific rationale and preliminary evidence, the overall strength of the evidence remains low, and maitake should not be considered a substitute for established HIV/AIDS treatments.

More about maitake mushroom
More about Acquired Immune Deficiency Syndrome